PharmaCyte Biotech Inc. has published a report announcing its increased investment in TNF Pharmaceuticals, which is set to undergo a name and ticker symbol change to align with its new strategic focus on revolutionary computing technologies for cryptocurrency applications.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PharmaCyte Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-25-006727), on September 05, 2025, and is solely responsible for the information contained therein.